1. PET/CT with 68Gallium-DOTA-peptides in NET: An overview
- Author
-
Davide Campana, Valentina Ambrosini, Stefano Fanti, Paola Tomassetti, Domenico Rubello, Gaia Grassetto, Ambrosini V., Campana D., Tomassetti P., Grassetto G., Rubello D., and Fanti S.
- Subjects
DOTA-TATE ,PET-CT ,medicine.medical_specialty ,business.industry ,Gallium Radioisotopes ,General Medicine ,Multimodal Imaging ,NET ,Neuroendocrine Tumors ,chemistry.chemical_compound ,68Gallium-DOTA ,chemistry ,Positron-Emission Tomography ,Scintigraphic imaging ,Organometallic Compounds ,medicine ,Humans ,DOTA ,Radiology, Nuclear Medicine and imaging ,Medical physics ,Radiopharmaceuticals ,Tomography, X-Ray Computed ,Nuclear medicine ,business - Abstract
In the present review article we presented the major technical innovations regarding the diagnosis of NET with PET/CT 68Ga-DOTA-peptides compounds over conventional radiologic and scintigraphic imaging, discussing both the different types of radiopharmaceuticals commercially available, trying to making a comparison on the possible advantages and drawbacks of these radiopharmaceuticals, and providing also some technical recommendations to the radiologists and nuclear physicians for using these new methodology in an appropriate manner in the clinical setting.
- Published
- 2011